Evidence map›Paper›PMID 36762213›Full record

ArticleGastroenterology and hepatology from bed to bench2022

Expression and methylation status of

Mehran Erfani, Mozhdeh Zamani, Gholamhossein Tamaddon, Seyed Vahid Hosseini, Pooneh Mokarram

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology and hepatology from bed to bench, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mehran ErfaniDepartment of Biochemistry, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mozhdeh ZamaniColorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Gholamhossein TamaddonDepartment of Clinical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Vahid HosseiniColorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pooneh MokarramDepartment of Biochemistry, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IRHormozgan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study investigated the association between methylation status and expression levels of Background: Aberrant DNA methylation is one of the most important epigenetic modifications in the development of cancer. Evidence indicates that hypermethylation of various tumor suppressor genes could be a potential mechanism of colon tumorigenesis. Methods: The expression levels of Results: The expression levels of Conclusion: Overall, it seems that

Indexed as

BTG2Colon cancerDNAPEG3PPP1CA

Identifiers

PMID36762213
PMCPMC9876769
OpenAlexW4319826680

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.